Birmingham biotech company receives $1.2M toward research By: Birmingham Business Journal via Business Journals June 15, 2022 at 23:14 PM EDT A Birmingham biotech company has received over a million dollars in funding toward research to treat a chronic kidney disease. Read More >> Related Stocks: Harbor Disruptive Innovation ETF